TY - JOUR
T1 - A case of solitary subependymal giant cell astrocytoma
T2 - Two somatic hits of TSC2 in the tumor, without evidence of somatic mosaicism
AU - Ichikawa, Tomotsugu
AU - Wakisaka, Akiko
AU - Daido, Shigeru
AU - Takao, Soichiro
AU - Tamiya, Takashi
AU - Date, Isao
AU - Koizumi, Shoichi
AU - Niida, Yo
N1 - Funding Information:
Supported by personal grant of Department of Pediatrics, Kanazawa University Graduate School of Medical Science.
PY - 2005/10
Y1 - 2005/10
N2 - Subependymal giant cell astrocytoma (SEGA) is a unique brain tumor arising in tuberous sclerosis complex (TSC), an autosomal dominant inherited phacomatosis. There are several case reports of solitary SEGA without any other manifestations of TSC. Usually these cases are thought to be forme fruste of TSC due to somatic mosaicism. However, no previous reports have used molecular methodology to fully investigate mutations in TSC genes or the possibility of somatic mosaicism. Here, we report a 20-year-old woman with a brain tumor. Pathological diagnosis was consistent with SEGA, but comprehensive clinical screening found no other lesions indicative of TSC. Molecular analysis of the tumor revealed loss of heterozygosity and allelic mutation (5228G>A, R1743Q) of TSC2. To detect the small fraction of mosaic mutation in somatic cells, we developed a highly sensitive new method: triple-nested polymerase chain reaction-restriction fragment length polymorphism. The identical TSC2 missense mutation was not detected in any other tissues from the same patient, including peripheral blood, buccal mucosa, urinary sediment, nail, and hair. According to these results, this patient should be considered as having SEGA that developed from two somatic hit mutations in TSC2, rather than being a TSC2 patient with a very small fraction of somatic mosaicism.
AB - Subependymal giant cell astrocytoma (SEGA) is a unique brain tumor arising in tuberous sclerosis complex (TSC), an autosomal dominant inherited phacomatosis. There are several case reports of solitary SEGA without any other manifestations of TSC. Usually these cases are thought to be forme fruste of TSC due to somatic mosaicism. However, no previous reports have used molecular methodology to fully investigate mutations in TSC genes or the possibility of somatic mosaicism. Here, we report a 20-year-old woman with a brain tumor. Pathological diagnosis was consistent with SEGA, but comprehensive clinical screening found no other lesions indicative of TSC. Molecular analysis of the tumor revealed loss of heterozygosity and allelic mutation (5228G>A, R1743Q) of TSC2. To detect the small fraction of mosaic mutation in somatic cells, we developed a highly sensitive new method: triple-nested polymerase chain reaction-restriction fragment length polymorphism. The identical TSC2 missense mutation was not detected in any other tissues from the same patient, including peripheral blood, buccal mucosa, urinary sediment, nail, and hair. According to these results, this patient should be considered as having SEGA that developed from two somatic hit mutations in TSC2, rather than being a TSC2 patient with a very small fraction of somatic mosaicism.
UR - http://www.scopus.com/inward/record.url?scp=26944463473&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=26944463473&partnerID=8YFLogxK
U2 - 10.1016/S1525-1578(10)60586-7
DO - 10.1016/S1525-1578(10)60586-7
M3 - Article
C2 - 16237225
AN - SCOPUS:26944463473
SN - 1525-1578
VL - 7
SP - 544
EP - 549
JO - Journal of Molecular Diagnostics
JF - Journal of Molecular Diagnostics
IS - 4
ER -